United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 584,700 | 306,600 | 984,800 | 767,700 | 500,100 |
| Depreciation Amortization | 33,700 | 15,000 | 53,200 | 39,500 | 26,200 |
| Accounts receivable | -11,800 | -28,300 | -58,500 | -38,200 | -52,200 |
| Accounts payable and accrued liabilities | 27,700 | 1,900 | 57,100 | 80,200 | 40,800 |
| Other Working Capital | -69,000 | 39,800 | -97,800 | -6,100 | -52,100 |
| Other Operating Activity | 43,400 | 41,500 | 39,200 | -15,800 | 18,300 |
| Operating Cash Flow | $608,700 | $376,500 | $978,000 | $827,300 | $481,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,500 | 302,500 | -2,514,300 | -2,206,300 | -1,561,500 |
| PPE Investments | -83,300 | -38,200 | -230,400 | -151,700 | -86,000 |
| Net Acquisitions | N/A | N/A | -89,200 | N/A | N/A |
| Purchase Of Investment | -4,700 | -4,300 | -23,000 | -14,300 | -3,700 |
| Sale Of Investment | 671,800 | 475,300 | 2,137,300 | 1,610,600 | 1,202,900 |
| Investing Cash Flow | $655,300 | $735,300 | $-719,600 | $-761,700 | $-448,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98,200 | 46,100 | 104,600 | 97,300 | 89,500 |
| Common Stock Repurchased | -1,011,500 | -1,011,400 | -13,800 | -13,700 | -13,500 |
| Other Financing Activity | -202,700 | -102,700 | -102,700 | -2,700 | -2,700 |
| Financing Cash Flow | $-1,116,000 | $-1,068,000 | $-11,900 | $80,900 | $73,300 |
| Beginning Cash Position | 1,207,700 | 1,207,700 | 961,200 | 961,200 | 961,200 |
| End Cash Position | 1,355,700 | 1,251,500 | 1,207,700 | 1,107,700 | 1,067,300 |
| Net Cash Flow | $148,000 | $43,800 | $246,500 | $146,500 | $106,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 608,700 | 376,500 | 978,000 | 827,300 | 481,100 |
| Capital Expenditure | -83,300 | -38,200 | -230,400 | -151,700 | -86,000 |
| Free Cash Flow | 525,400 | 338,300 | 747,600 | 675,600 | 395,100 |